AGN.AX
Price:
$0.25
Market Cap:
$32.11M
Argenica Therapeutics Limited engages in the research and development of a neuroprotective therapeutic drug in Australia. Its lead product candidate is ARG-007, a neuroprotective peptide candidate use to protect brain cells and reduce cell death during a stroke and other types of neural injuries. The company was incorporated in 2019 and is based in Nedlands, Australia.
Industry
Biotechnology
IPO Date
2021-06-11
Stock Exchange
ASX
Ticker
AGN.AX
According to Argenica Therapeutics Limited’s latest financial reports and current stock price. The company's current PE Ratio is -4.17. This represents a change of -52.09% compared to the average of -8.70 of the last 4 quarters.
The mean historical PE Ratio of Argenica Therapeutics Limited over the last ten years is -17.70. The current -4.17 PE Ratio has changed 2.26% with respect to the historical average. Over the past ten years (40 quarters), AGN.AX's PE Ratio was at its highest in in the December 2020 quarter at 72.90. The PE Ratio was at its lowest in in the December 2019 quarter at -23780.98.
Average
-17.70
Median
-13.87
Minimum
-49.62
Maximum
-6.82
Discovering the peaks and valleys of Argenica Therapeutics Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 108.86%
Maximum Annual PE Ratio = -6.82
Minimum Annual Increase = -71.35%
Minimum Annual PE Ratio = -49.62
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -13.52 | -5.11% |
| 2024 | -14.25 | 108.86% |
| 2023 | -6.82 | -12.23% |
| 2022 | -7.77 | -45.33% |
| 2021 | -14.22 | -71.35% |
The current PE Ratio of Argenica Therapeutics Limited (AGN.AX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-11.53
5-year avg
-11.31
10-year avg
-17.70
Argenica Therapeutics Limited’s PE Ratio is greater than Noxopharm Limited (-5.92), greater than Prescient Therapeutics Limited (-9.27), greater than BCAL Diagnostics Limited (-4.87), less than Microba Life Sciences Limited (-2.25), greater than INOVIQ Ltd (-5.55), less than Nova Eye Medical Limited (-4.10), greater than AnteoTech Limited (-10.52), greater than Emyria Limited (-8.33), less than Immuron Limited (-2.91), greater than Tissue Repair Ltd (-4.71),
| Company | PE Ratio | Market cap |
|---|---|---|
| -5.92 | $28.93M | |
| -9.27 | $89.38M | |
| -4.87 | $36.78M | |
| -2.25 | $33.58M | |
| -5.55 | $38.79M | |
| -4.10 | $39.87M | |
| -10.52 | $46.37M | |
| -8.33 | $32.73M | |
| -2.91 | $17.33M | |
| -4.71 | $19.95M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Argenica Therapeutics Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Argenica Therapeutics Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Argenica Therapeutics Limited's PE Ratio?
How is the PE Ratio calculated for Argenica Therapeutics Limited (AGN.AX)?
What is the highest PE Ratio for Argenica Therapeutics Limited (AGN.AX)?
What is the 3-year average PE Ratio for Argenica Therapeutics Limited (AGN.AX)?
What is the 5-year average PE Ratio for Argenica Therapeutics Limited (AGN.AX)?
How does the current PE Ratio for Argenica Therapeutics Limited (AGN.AX) compare to its historical average?